Podcasts about The Home Depot

In this episode of Live Greatly: 2 Minutes of Motivation, Kristel Bauer shares a powerful mindset shift to help you navigate change more effectively at work. Change is inevitable, but it's also something many professionals naturally resist. Our brains are wired for predictability, and when routines are disrupted, it can trigger stress, uncertainty, and overwhelm. The good news? With the right perspective, change doesn't have to feel so overwhelming. In this episode, Kristel shares insights grounded in research on adaptability and performance to help make workplace change more manageable. You'll learn how a simple mental shift can help reduce resistance, build resilience, and support sustainable high performance during times of transition. Hosted by Kristel Bauer, keynote speaker, author, and performance expert. Book Kristel for Your Event or Team Bring these strategies to your organization:

Simon and Dan kick off with a quick update on the Canadian Investor Podcast’s first YouTube Live (March 3rd at noon ET). Then it’s straight into the GoEasy saga: Q4 earnings get pushed right up near the regulatory deadline, adding to a growing list of red flags around leadership turnover and loan-book quality. Simon and Dan explain why, like poker, you can’t cherry-pick the information you like. Next, Canadian Tire shows momentum: improving comps, margin expansion, and buybacks doing the heavy lifting—plus a look at rising credit-card write-offs and how the company is using AI to sharpen promos and inventory. They also dig into Blue Owl as private credit stress goes mainstream—redemptions, asset sales, and “par value” optics in a mark-to-model world. Finally, Home Depot remains stuck in a slow renovation cycle, leaning harder into the pro/distribution channel through acquisitions as higher rates weigh on demand. Tickers discussed: GSY, CTC.A, OWL, BAM, BN, HD, BRK.B Watch the full video on Our New Youtube Channel! Check out our portfolio by going to Jointci.com Our Website Canadian Investor Podcast Network Twitter: @cdn_investing Simon’s twitter: @Fiat_Iceberg Braden’s twitter: @BradoCapital Dan’s Twitter: @stocktrades_ca Want to learn more about Real Estate Investing? Check out the Canadian Real Estate Investor Podcast! Apple Podcast - The Canadian Real Estate Investor Spotify - The Canadian Real Estate Investor Web player - The Canadian Real Estate Investor Asset Allocation ETFs | BMO Global Asset Management Sign up for Fiscal.ai for free to get easy access to global stock coverage and powerful AI investing tools. Register for EQ Bank, the seamless digital banking experience with better rates and no nonsense.See omnystudio.com/listener for privacy information.

PLUS: GA Sen. Dolezal plays 'lie by omission' game on voter registration laws & finally someone notices renters are getting screwed in tax cut conversations under the Gold Dome.After Trumps' 'State of the Union' marathon, Ron caught up with Atlanta-based political consultant Andrew Heaton to talk about the many false economic claims, Donald's push to replace income taxes with 'consumption tax' tariffs, and why Democrats may be missing opportunities to challenge the bigger issues — including ICE enforcement and the Epstein files.They also discuss whether Democrats should change their strategy when it comes to responding to Trump's speeches. Perhaps by pre-butting instead of rebutting. Andrew and Ron also dive into the Georgia gubernatorial race now with Rick Jackson's entry on the Republican side changing the dynamic for Burt Jones; he may need to be on the minds of Democratic voters when deciding who their nominee will be. In the second half of the show, CNN's Daniel Dale fact-checks the 'State of the Union,' to which I add where the affordability crisis can actually be traced back to a former President whose initials are DJT, with ramifications right up to the peak of post-pandemic inflation. Also, a notable Home Depot earnings report provides insights into the Trump-era housing slump, two Democrats step up to run for state Supreme Court seats, and finally someone's noticing that all these discussions in the state legislature to lower income and/or property taxes not only leaves renters out, but actually puts more of the tax burden on them to make up the funding gap.Lastly, Ron offers a warning to liberals and progressives doing that performative outrage thing and ensnaring the men's hockey team in their web of disdain. Tune in to catch the Ron Show weekdays from 4-6pm Eastern time on Georgia NOW! Grab the app or listen online at heargeorgianow.com.#HearGeorgiaNow #TheRonShow #AndrewHeaton #StateOfTheUnion #TrumpSpeech #RickJackson #BurtJones #KeishaLanceBottoms #GeorgiaPolitics #EpsteinFiles

In our bonus interview, CPC attorney Emily Rae unpacks the new U.S. Department of Education report showing how state officials use lawsuits, funding, and threats to force school officials to violate federal law regarding parent notification. In other news: Alex Padilla has missed another chance to thank federal officers who didn't shoot him last June. Representative Lateefah Simon (D., Calif.) hates the Treaty of Guadalupe Hidalgo but won't leave California. L.A. Mayor Karen Bass threatens to punish property owners who welcome ICE agents. Republican gubernatorial candidates surge, Dems end their panicky convention with no clear endorsement. Music by Metalachi. Email Us:dbahnsen@thebahnsengroup.comwill@calpolicycenter.org Follow Us:@DavidBahnsen@WillSwaim@TheRadioFreeCA Show Notes: After State of the Union, Democrats say Trump did ‘what he does best: lie' The Padilla Incident and the Greater Peril H.Res.1056 - Calling for the annulment of the Monroe Doctrine and the development of a "New Good Neighbor" policy Mexican army kills ‘El Mencho,' Mexico's most-wanted drug kingpin LA Mayor Karen Bass announces plans to ban ICE from city properties Coalition rallies to defend Cypress Park day labor center amid disputed Home Depot eviction threat Newsom to Middle Class Whites: I'm Average Too Newsom Pardon Allows Illegal Immigrant to Remain in U.S. Despite Attempted Murder Conviction ‘I'm very worried': California Dems confront possibility of an all-GOP governor race L.A. County pushes to change law that opened floodgates for billions in sex abuse payouts LAUSD borrowing $250 million to settle sex abuse claims — on top of earlier half billion Despite climate effects, beaches grew 500 acres Emily Rae, California Justice Center, on U.S. Department of Ed report: Emily Rae bio U.S. Department of Education letter to California  Emily's amicus brief in Littlejohn Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jordan Morris is known to Maximum Fun fans as the funny and engaging co-host of Jordan, Jesse, Go! and Free With Ads. He also makes comics, such as the new Predator: Bloodshed series. It's all about the Predator, monster sci-fi icon, and his efforts to purchase and install a new shed to put all his blood in. He goes to Home Depot, he tries building one himself after watching YouTube videos, but all the sheds leak blood out, ruining the Predator's begonias. None of that is true. But there really is a Predator: Bloodshed series, Jordan is behind it, and it's quite entertaining, as is Jordan. On our program, Jordan tells us all about the many iterations of Godzilla and how the canonical word for the sound Godzilla makes is “skreeonk.” Will it be hard to sleep thinking about Godzilla? No. You're not a building. You'll be fine. Get your copy of Predator: Bloodshed wherever comics are sold. Listen and subscribe to Jordan, Jesse, Go! and Free With Ads on the podcatcher of your choice. Hey Sleepy Heads, is there anyone whose voice you'd like to drift off to, or do you have suggestions on things we could do to aid your slumber? Email us at: sleepwithcelebs@maximumfun.org. Follow the Show on: Instagram @sleepwcelebs Bluesky @sleepwithcelebs TikTok @SleepWithCelebs John is on Bluesky @JohnMoe John's acclaimed, best-selling memoir, The Hilarious World of Depression, is now available in paperback. _________________________________________________________________________ Join | Maximum Fun If you like one or more shows on MaxFun, and you value independent artists being able to do their thing, you're the perfect person to become a MaxFun monthly member.

Paul Lane and Marc Fandetti break down the market rebound following another AI disruption scare and examine whether fears of massive white-collar job losses are overblown. They debate how artificial intelligence could reshape competition in the U.S. economy — potentially disrupting dominant tech firms while opening the door for new startups.The hour also covers renewed tariff uncertainty after the Supreme Court ruling, a $100 billion Meta–AMD AI deal, Home Depot's latest earnings amid a frozen housing market, and growing risks building in private credit. Plus, the hosts discuss what concentrated market exposure could mean for investors in 2026.

En el episodio de hoy de VG Daily, Juan Manuel de los Reyes y Andre Dos Santos analizan los tres grandes miedos impulsados por la Inteligencia Artificial. El masivo gasto de las “Big Tech”, la inminente disrupción en los modelos de negocio de software (y su riesgo para el private equity) y el fantasma del desempleo están alterando el panorama para los inversores.Lejos de entrar en pánico, el dinero no está saliendo de la bolsa, sino que está protagonizando una rotación sectorial histórica. Se analiza a fondo los recientes reportes de Home Depot, AMC, Lowe's, CAVA y TJX para entender exactamente hacia dónde está fluyendo el capital y por qué el S&P 500 Equal Weight se ha convertido en el verdadero protagonista de este ciclo.

Ihr kriegt aktuell 25 € vom Scalable-ETF, wenn ihr ein neues Konto eröffnet und nutzt. Dazu unterstützt ihr auch noch diesen Podcast. Mehr Infos gibt's hier. Meta kauft AMD-Chips für Milliarden. Anthropic stellt Plug-Ins vor, Salesforce und Co. profitieren. Home Depot wächst online zweistellig. Keysight mit starkem Ausblick. Novo Nordisk halbiert Wegovy-Preis. MTU wird Erwartungen nicht gerecht. Elmos +40% YTD. JPMorgan (WKN: 850628) eröffnet 160 neue Filialen und will 15% aller US-Privatkundeneinlagen halten. Auch PNC (WKN: 867679) setzt auf Expansion. Sterben Bankfilialen doch nicht aus? Jungheinrich (WKN: 621993) kämpft mit chinesischer Konkurrenz und internem Familienstillstand. Gleichzeitig läuft der Umbau zum Tech-Konzern. Schafft die gelbe Ameise die Verdopplung auf 10 Mrd. € Umsatz? Diesen Podcast vom 25.02.2026, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

Looking to boost creativity, build a purpose-driven brand, or achieve sustainable success without burnout? In this Live Greatly podcast episode, Kristel Bauer sits down with Paige Mycoskie, founder and president of Aviator Nation, for an inside look at how she built one of the most recognizable California lifestyle brands in the world. Paige shares her journey from working in a surf shop to leading a globally loved company — along with her approach to creativity, leadership, company culture, and well-being. You'll also hear how she manages stress, protects her energy, and stays grounded while growing a high-impact brand. This inspiring conversation offers powerful insights for entrepreneurs, leaders, and anyone looking to build success with authenticity and balance. Tune in now! Key Takeaways from This Episode: A look into how Aviator Nation got started How Paige went from working at a surf shop to being the founder of Aviator Nation What Paige does do to boost creativity A look into Paige's leadership style How Paige finds inner balance and manages stress Why Aviator Nation's clothes are made in America Fun things in the works for Aviator Nation About Paige Mycoskie: FOUNDER & PRESIDENT OF AVIATOR NATION Paige Mycoskie is an American artist, fashion designer, and businesswoman, best known as the founder and owner of the 70's-inspired California lifestyle brand, Aviator Nation.  Paige was named GQ Magazines Designer of the Year, one of LA Business Journals Top Bosses Under 30 and was featured in Forbes Magazine as one of the United State's most successful female founders. Born in Texas, and an avid athlete, she was a state Volleyball champion, and on the Arizona State University Water Ski Team all while attending the Walter Cronkite School for Journalism.  Paige began her career at Shape Magazine and shifted focus to freelance photography, video, graphic design, and branding. She developed successful campaigns in branding and commercials, including TOMS Shoes.  Paige then decided to create her own clothing line - sewing, dying, and designing each piece herself.   Her beloved brand, Aviator Nation, was established in 2006 with the focus to create quality Made in America clothing.  Another goal for Paige was to connect fashion with music while raising funds for charities and generating an awareness of our collective consciousness.  Today Aviator Nation is a multi-million dollar business with 16 store locations across the US – including event space Dreamland in Malibu and wellness studio, RIDE, in Santa Monica - and a factory in downtown Los Angeles that employs over 300 people.  The garments are still Made in America after 15 years and Paige continues to inspire other companies to push the limits on manufacturing local.  With a passion for philanthropy, she has worked with a variety of nonprofits including Charity Water; Surf Aid; Heal the Bay; The Flatwater Foundation; and Global Citizen with proceeds aiding in their ongoing campaign to end poverty. The brand also has partnerships with SXSW, Austin City Limits Music Festival; Lollapalooza Music Festival; and with John Mayer's previous concert tours. Website: https://www.aviatornation.com/  Instagram: @aviatornation @paigemycoskie LinkedIn: https://www.linkedin.com/in/paige-mycoskie-17a9b56/  https://www.linkedin.com/company/aviator-nation/  Facebook: https://www.facebook.com/AviatorNation/  Hosted by Kristel Bauer, keynote speaker, author, and performance expert. Book Kristel for Your Event or Team Bring these strategies to your organization:

Carl Quintanilla, Jim Cramer and David Faber explored what's next for the markets after Monday's sell-off, which was sparked by AI fears and tariff uncertainty. The anchors also delved into the conundrum surrounding the private credit markets — and reacted to what JPMorgan Chase CEO Jamie Dimon said about the risks. AMD shares surged on news of the company's multiyear AI chip agreement with Meta Platforms. AMD Chair & CEO Lisa Su joined the program exclusively to talk about the deal. Also in focus: Home Depot's earnings beat, Anthropic announces new AI tools, State of the Union speech countdown, Warner Bros. Discovery says it is reviewing Paramount Skydance's new takeover offer.    Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send a textIs NASCAR Evolving In The Right Direction? The guys discuss the current state of NASCAR and discuss it's history and advertising.Buy the guys some guzzoline! https://buymeacoffee.com/getoutndriveThe Get Out N Drive Podcast is Fuel By AMD ~ AMD: More Than Metal https://www.autometaldirect.com/Visit the ‪AMD‬​ Garage ~ Your one stop source for high quality body panels for your restorationhttps://www.autometaldirect.com/amdgarageFor all things Get Out N Drive, cruise on over to the Get Out N Drive website. https://getoutndrive.com/Be sure to follow GOND on social media!GOND Website: https://getoutndrive.com/IG: https://www.instagram.com/getoutndrivepodcast/X: https://x.com/getoutndrivepodFB: https://www.facebook.com/Get.Out.N.Drive.podcastYouTube: https://www.youtube.com/@getoutndriveRecording Engineer: Paul MeyerSubscribe to the ‪Str8sixfan‬​ YouTube Channel:  @Str8sixfan  #classiccars​ #automotive​ #amd #autometaldirect #c10 #restoration #autorestoration #autoparts #restorationparts #truckrestoration #Jasonchandler #podcast #sheetmetal #mecum #bobbyadams #mecumscandal #carauction #classiccarauction #usedcar #buyaclassiccar #sellaclassiccar#tradeschool​#carengines​#WhatDrivesYOUth​#GetOutNDriveFAST​Join our fb group to share pics of how you Get Out N Drive: https://www.facebook.com/groups/getoutndrivepodcast/Follow Jason on IG: https://www.instagram.com/oldecarrguy/Follow Jason on fb: https://www.facebook.com/oldecarrguySubscribe To the OldeCarrGuy YouTube Channel:  @OldeCarrGuy  Follow John on IG: https://www.instagram.com/customcarnerd/Recording Engineer, Paul MeyerSign Up and Learn more about National Get Out N Drive Day: https://nationalgetoutndriveday.com/Music Credit:Licensor's Author Username:LoopsLabLicensee:Get Out N Drive PodcastItem Title:The RockabillyItem URL:https://audiojungle.netItem ID:25802696Purchase Date:2022-09-07 22:37:20​ UTCSupport the show: https://buymeacoffee.com/getoutndrive#ClassicCarSupport the show

After a Monday marked by trade-related uncertainty, key software, consumer, and tech results vie for attention today and tomorrow, starting with Home Depot. Nvidia looms Wednesday. Important Disclosures This material is intended for general informational purposes only. This should not be considered an individualized recommendation or personalized investment advice. The investment strategies mentioned may not be suitable for everyone. Each investor needs to review an investment strategy for his or her own particular situation before making any investment decisions. The Schwab Center for Financial Research is a division of Charles Schwab & Co., Inc. All names and market data shown above are for illustrative purposes only and are not a recommendation, offer to sell, or a solicitation of an offer to buy any security. Supporting documentation for any claims or statistical information is available upon request. Past performance is no guarantee of future results. Diversification and rebalancing strategies do not ensure a profit and do not protect against losses in declining markets. Indexes are unmanaged, do not incur management fees, costs, and expenses and cannot be invested in directly. For more information on indexes, please see schwab.com/indexdefinitions. The policy analysis provided by the Charles Schwab & Co., Inc., does not constitute and should not be interpreted as an endorsement of any political party. Fixed income securities are subject to increased loss of principal during periods of rising interest rates. Fixed income investments are subject to various other risks including changes in credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications, and other factors. All expressions of opinion are subject to change without notice in reaction to shifting market, economic or political conditions. Data contained herein from third party providers is obtained from what are considered reliable sources. However, its accuracy, completeness or reliability cannot be guaranteed. Investing involves risk, including loss of principal, and for some products and strategies, loss of more than your initial investment. Digital currencies [such as bitcoin] are highly volatile and not backed by any central bank or government. Digital currencies lack many of the regulations and consumer protections that legal-tender currencies and regulated securities have. Due to the high level of risk, investors should view digital currencies as a purely speculative instrument. Cryptocurrency-related products carry a substantial level of risk and are not suitable for all investors. Investments in cryptocurrencies are relatively new, highly speculative, and may be subject to extreme price volatility, illiquidity, and increased risk of loss, including your entire investment in the fund. Spot markets on which cryptocurrencies trade are relatively new and largely unregulated, and therefore, may be more exposed to fraud and security breaches than established, regulated exchanges for other financial assets or instruments. Some cryptocurrency-related products use futures contracts to attempt to duplicate the performance of an investment in cryptocurrency, which may result in unpredictable pricing, higher transaction costs, and performance that fails to track the price of the reference cryptocurrency as intended. Please read more about risks of trading cryptocurrency futures here. The Schwab Center for Financial Research is a division of Charles Schwab & Co., Inc. Apple Podcasts and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. Google Podcasts and the Google Podcasts logo are trademarks of Google LLC. Spotify and the Spotify logo are registered trademarks of Spotify AB. (0128-0226) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Mike Armstrong and Paul Lane break down the market rebound after an AI-driven selloff sparked fears of white-collar job disruption. They examine whether the latest wave of artificial intelligence concerns represents real structural risk — or short-term market overreaction.Mike and Paul also dive into ongoing tariff uncertainty following the Supreme Court ruling, the complications surrounding potential refunds, and what shifting trade policy means for businesses and consumers. Plus, they analyze Home Depot earnings and what stubbornly slow housing activity signals about the broader economy.

Mike Armstrong and Paul Lane break down the fallout after the Supreme Court struck down key Trump-era tariffs — only for new tariffs to be reintroduced days later. With billions in potential refunds at stake and uncertainty surrounding Congress's next move, the hosts examine what this policy whiplash means for businesses, consumers, and long-term investment decisions.The hour also covers Meta's massive AI deal with AMD, growing concerns about artificial intelligence disrupting white-collar jobs, and Home Depot's earnings as a window into the state of the consumer economy.

Following Home Depot's (HD) latest earnings print, Sky Canaves calls the report a "much needed beat." She points to a frozen housing market as something that could be weighing on the company's "conservative" guidance. For the year ahead, she's paying attention to affordability concerns for HD's consumer base as well as the company's efforts to gain market share against rival Lowe's (LOW) in its Pro segment. Sky sees Home Depot growing more than Lowe's in e-commerce initiatives in 2026.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about

Jaime Katz with @morningstar talks about Home Depot's (HD) earnings and ways its navigated sticky inflation and a struggling housing industry. She also sets the foundation for Lowe's (LOW) earnings by previewing Wednesday morning's report. George Tsilis turns to an example options trade for Home Depot. ======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about

Market update for Tuesday February 24, 2026Check out the Public app for incredible investing tools and to support the show (LINK)Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.In today's episode:A viral AI “doomsday” report spooks investorsMeta strikes a massive $100B+ AI chip deal with AMDHome Depot beats earnings but warns housing demand remains “frozen”BWX Technologies surges as nuclear momentum buildsHims & Hers drops on weak guidance and weight-loss drug lawsuitUber acquires SpotHero, expanding deeper into the transportation ecosystem

APAC mostly firmer as China returned, somewhat shrugging off the weak Wall St. finish on AI disruption concerns.DXY marginally firmer, EUR/USD directionless, while USD/JPY edged higher and above 155.00.USTs pulled back from Monday's best, Bunds remained near highs, while JGBs saw choppy action after the long weekend.Crude remained tentative amid ongoing geopolitical uncertainty, XAU faded while copper rallied as China returned.Looking ahead, highlights include US ADP Weekly, House Prices (Dec), Consumer Confidence (Feb), Dallas/Richmond Fed (Feb), Atlanta Fed GDP, NBH Policy Announcement, Speakers including ECB's Lagarde, BoE's Bailey, Lombardelli, Greene, Taylor & Pill, Fed's Goolsbee, Collins, Bostic, Waller, Cook & Barkin, Supply from UK, Italy & US, Earnings from Home Depot & Keurig Dr Pepper.Click for the Newsquawk Week Ahead.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

European bourses slip as AI concerns hit European Banks; US equity futures rebound slightly.JPY dragged on reports PM Takaichi raised reservations about rate hikes to BoJ Governor Ueda; DXY slightly firmer.Gilts notch a fresh contract high into the TSC, USTs rangebound heading into heavy speaker docket.WTI and Brent mildly gains; Spot gold retreats from Monday's best while Copper gains as mainland China returns. Looking ahead, highlights include US ADP Weekly, House Prices (Dec), Consumer Confidence (Feb), Dallas/Richmond Fed (Feb), Atlanta Fed GDP, NBH Policy Announcement, Speakers including ECB's Lagarde, BoE's Bailey, Greene, Taylor & Pill, Fed's Goolsbee, Collins, Bostic, Waller, Cook & Barkin, Supply from the US, Earnings from Home Depot & Keurig Dr Pepper.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Die US-Börsen stabilisieren sich nach dem gestrigen Sell-off, der Nasdaq wird vor allem von AMD getragen: Meta schließt einen Mehrjahresdeal über bis zu 6 Gigawatt für AMD Instinct GPUs ab – inklusive eines leistungsabhängigen Warrants über bis zu 160 Mio. Aktien. Gleichzeitig bleibt das dominante Thema KI-Angst 2.0: Um 9:30 Uhr ET startet das Anthropic „Enterprise Agent“-Event, das die Disruptionsdebatte erneut anheizen könnte. Makroseitig mahnen Goolsbee und Waller zur Vorsicht – 3% Kerninflation sei „nicht gut genug“, Cuts werden eher nach hinten geschoben. On top setzt Stripe mit 159 Mrd. USD Bewertung und 1,9 Bio. USD Zahlungsvolumen 2025 (+34%) ein starkes Fintech-Signal. Bei den Zahlen überzeugt Home Depot im Quartal, während der 2026-Ausblick eher gedämpft bleibt. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Meta, AMD, Home Depot, FedEx, IMB...bajo la lupa de Julián Coca, gestor de fondo Alinea Global.

Los tres principales índices de Bolsas americanas suben con solidez a primera hora. Los inversores siguen evaluando los últimos avances en inteligencia artificial. Hoy presenta novedades anthropic que se centran en tareas de banca de inversión, RRHH e ingeniería. Las acciones de Fair Isaac, AppLovin y Palantir bajan. Pero los títulos de FactSet, Salesforce, DocuSign ganan porque Anthropic las incluye como socios de desarrollo. Los comentarios de los responsables políticos sobre el impacto de la IA también son una mezcla interesante. La gobernadora de la Reserva Federal, Lisa Cook afirma que la inteligencia artificial podría provocar un posible aumento de la tasa de desempleo que el banco central estadounidense tal vez no pueda contrarrestar con tipos de interés más bajos. Sin embargo, el gobernador Christopher Waller dice que no espera que la adopción de la tecnología de IA destroce el mercado laboral en Estados Unidos. Consumo discrecional es el mejor sectorial. Royal Caribbean, Ford Motor y Home Depot sus mejores valores. Analizamos el mercado con Ángel Pérez Llamazares, de Renta 4 Banco. Hablamos, entre otras cosas, de Endesa y Telefónica.

Los futuros de los índices bursátiles estadounidenses recuperan algunas pérdidas el martes tras una dolorosa venta en la sesión anterior, mientras los inversores lidian con la incertidumbre sobre las políticas arancelarias del presidente Donald Trump y las crecientes preocupaciones sobre la inteligencia artificial. A la cabeza de la recuperación está Advanced Micro Devices , que se disparó un 14% después de que el fabricante de chips dijera que ha acordado vender hasta 60.000 millones de dólares en chips de inteligencia artificial a Meta Platforms a lo largo de cinco años. Además, Meta adquiere el 10% de AMD por 40.000 millones. Home Depot gana un 2% después de que el minorista superara las estimaciones con sus resultados del cuarto trimestre y mantuviera sus previsiones anuales. Analizamos el mercado con Nicolás López, de Singular Bank. En Bolsa española, lideran las subidas en Ibex35 Endesa, tras resultados, Acciona y Merlin Properties. Los que más pierden son Logista, Santander y Caixabank.

Der Zoll-Nebel bleibt: Nach dem Urteil des US Supreme Court ist unklar, wie es mit US-Zöllen weitergeht und wie belastbar ein EU-US-Deal wäre. Der DAX klebt am 25.000er-Pflaster und schließt bei 24.986 Punkten, -0,02 %. Gewinner sind Autohersteller, Verlierer MTU nach Zahlen und schwachem Free-Cashflow-Ausblick (-5,2 %). USA: AMD +6,6 % nach KI-Deal mit Meta (bis zu 60 Mrd. USD; Meta kann bis zu 10% an AMD übernehmen). Home Depot +3,9%: flächenbereinigter Umsatz +0,4%, Ausblick 2026: 0 %-2 % vergleichbares Wachstum. Lufthansa öffnet die neue Allegris Business Class in der 787-9 zur Buchung ab 29.03. Salzgitter kauft Thyrolf & Uhle, Telefónica Deutschland: Umsatz -3,8 % auf 8,2 Mrd. Euro, EBITDA -8,8 % auf 2,5 Mrd. Euro. Novo Nordisk/United Lab: UBT251 mit bis zu -19,7 % Gewichtsverlust in Phase 2. Ford ruft über 400.000 Explorer zurück. Rohstoffe: Gold 5.146,15 USD -1,56 %, Silber 87,78 USD -0,49 %. Öl bleibt nervös, Iran bleibt Risikofaktor.

U.S. equities rose on Tuesday, led by gains in Advanced Micro Devices and software stocks, as investors' fears around artificial intelligence disruption to certain industries eased.The S&P 500 advanced 0.77% to close at 6,890.07, while the Nasdaq Composite rose 1.04% and settled at 22,863.68. The Dow Jones Industrial Average added 370.44 points, or 0.76%, and ended at 49,174.50. The 30-stock index was supported by a nearly 2% rise in Home Depot shares after the company's earnings beat expectations for the first time in a year. IBM shares, which tumbled in the prior trading day as a result of aforementioned AI fears, also added to the Dow's gains.SPI up 61 - Results and CPI in focus.—Marcus Today – Daily Market InsightsMarcus Today provides clear, practical commentary for self-directed investors – covering markets, portfolios, education, and decision-making without the noise.If you'd like to go further:Start a free 14-day trial of Marcus Today http://bit.ly/mt-trial-podcastJoin Marcus Today Use code MTPODCAST for 10% off http://bit.ly/mt-join-podcast-offerMT20 – Managed ETF Portfolio A professionally managed portfolio run by Marcus Padley and the team, using ASX-listed ETFs with active market timing. http://bit.ly/mt20-podcastPrinciples – How We Think About Investing A short video series on timing, behaviour, and decision-making. No stock tips. http://bit.ly/mt-principles-podcast—Disclaimer This podcast is general information only and does not consider your personal circumstances. It is not personal financial advice.

Mike Armstrong and Marc Fandetti continue unpacking the fallout from the Supreme Court's decision to strike down key Trump-era tariffs, followed by the White House's swift move to implement new 15% global tariffs. They examine what the renewed trade uncertainty means for markets, business planning, foreign negotiations, and Congressional involvement in an election year.The hour also previews upcoming economic data and major earnings reports from Nvidia, Home Depot, and Salesforce, while exploring broader questions about AI-driven productivity, stock market valuations, and whether volatility is quietly rebuilding beneath the surface.

23/2 Trump, dazi globali al 25%: chi vince e chi perde, le analisi delle case d'affati. L'interrogativo sui rimborsi, le opzioni legali del presidente. Bessent: Gettito dei dazi invariato per il 2026, abbiamo alternative legali. Greer (rappresentante al commercio): accordi bilaterali rimangono in vigore. Futures Usa in rosso, dollaro e petrolio in calo. Corrono oro e argento, Bitcoin sotto 65mila dollari. Europa: l'aumento medio dei dazi è dello 0,8%. Parlamento verso il congelamento della ratifica degli accordi commerciali. Lagarde a Cbs: “nuovi dazi rischiano di sconvolgere equilibrio commerciale precedente. Disruption per le imprese”. Commissione: “condizioni non consentono commercio equo, bilanciato per entrambi”. Tajani a Bruxelles per riunione ministri esteri, partecipa da lì a G7 commercio. Oggi vertice Task Force Farnesina con imprese a Roma. In Usa: focus su cybersecurity (dopo release Claude Code) e credito privato (Blue Owl). Mercoledì la trimestrale delle trimestrali: Nvidia. Lo stesso giorno anche Salesforce, domani Home Depot e Lowe's. In Asia Giappone e Cina chiusi per festività. Il Kospi rompe un nuovo record, corre l'Hang-Seng e la borsa indiana. Cina: valutiamo da vicino dazi alternativi. Trump dal 31 marzo al 2 aprile da Xi Jinping. Futures europei in rosso. Focus su trimestrali, giovedì Stellantis. Mps la lista da 30 nomi per il rinnovo del Cda. BPM oggi assemblea straordinaria per modifiche statuto. Enel, buyback da 1mld, oggi a Milano il Piano Strategico.  Learn more about your ad choices. Visit megaphone.fm/adchoices

From a $12 first paycheck to quitting a six-figure corporate job. Clint from Tool Review Zone shares the raw, unfiltered truth about building a nearly 400K subscriber YouTube channel in the tool niche. We dig into how he accidentally started his channel through Amazon and Home Depot reviews, why he refuses brand deals he doesn't believe in, the real revenue breakdown of a product review channel, and why YouTube Shorts might actually be hurting your long-form content. About Clint: My name is Clint and I started the Tool Review Zone Channel around six years ago, and now do this full time as a career Connect With Clint: YouTube Channel What We Offer Creators Join Creator Communities. A place to gather with other creators every single day. This provides access to Our Private Discord Server, Monthly Mastermind Group, and MORE!  Hire Dusty To Be Your YouTube Coach YouTube Channel Reviews (Audit): Get a 7-10 minute personalized video review of your YouTube channel with honest, actionable feedback for just $50. Subscribe to our weekly newsletter: Each week I document what I'm doing in my business and creative journey, share new things I've discovered, mistakes I've made, and much more! All Tools Mentioned On The Show: The Ultimate Entrepreneurs Resource. This is the spreadsheet where I keep all of the tools mentioned by all the guests on the podcast. Follow The Show: Facebook /// X /// YouTube /// Instagram Timestamps: 0:00 — Clint's $12 First YouTube Paycheck (Cold Open) 0:25 — Welcome & Intro to Clint from Tool Review Zone 1:17 — The Accidental Origin Story: Amazon Reviews to YouTube 3:50 — The Moment He Knew YouTube Could Be Something More 4:47 — Quitting a Six-Figure Corporate Job for YouTube 5:45 — Niching Down: Why Sticking to Your Lane Matters 7:00 — The Tribalism Problem in Niche Content 8:20 — His Honest Take on YouTube Shorts (He Hates Them) 9:50 — How Shorts Subscribers Hurt Long-Form Performance 10:38 — SEO Strategy: Why He Stopped Playing the SEO Game 12:40 — Thumbnail & Packaging Evolution: Keep It Mysterious 14:44 — Full Monetization Breakdown: Ad Revenue & Affiliates 16:44 — YouTube Shopping Affiliate: The Revenue Stream Creators Are Sleeping On 18:07 — Mid-Roll Ad Break: Creator Hub Services 18:30 — External Links vs. YouTube Shopping Cart 19:15 — Off-Platform Strategy: TikTok, Instagram & Facebook 20:18 — What He'd Do Differently If Starting YouTube Today 21:45 — What's Next for Tool Review Zone 23:28 — He Does Everything Himself (No Team, No Editor) 24:17 — On-Camera Confidence: From Hyperventilating to Natural 25:50 — Parting Words: Don't Listen to Haters, Make a Creator Friend 29:10 — Outro & How to Connect                

In this Live Greatly 2 Minutes of Motivation episode, Kristel Bauer shares four powerful ways to build happiness and use it as a performance advantage at work and in life. Research shows that when you feel better, you perform better. In this episode, Kristel explores simple, practical strategies to boost well-being, resilience, and success — even in demanding environments. You'll learn how to: • Focus on what's within your control through healthy lifestyle habits • Build stronger, high-quality relationships • Increase happiness through volunteering and service • Strengthen optimism, gratitude, and empowering thinking • Tune into your own needs to sustain energy and motivation Whether you're navigating a busy career, leadership responsibilities, or personal goals, this episode offers tools you can apply immediately. Hosted by Kristel Bauer, keynote speaker, author, and performance expert. Book Kristel for Your Event or Team Bring these strategies to your organization:

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

We’re settling into our new time shift and catching up on your talkbacks — and that’s when we discover Bellio has been hiding a surprisingly spot-on celebrity impersonation. We also break down the ongoing Paramount–Skydance–Netflix deal and what it could mean for the future of entertainment, plus we get a returning call from Jay Leno that you won’t want to miss. Tim reminds everyone about the upcoming listener cruise, and we take a detour to check out Adam Carolla’s latest videos from Home Depot. There’s crosstalk with George Noory, a spirited debate over boneless vs. bone-in wings, and a deep dive into the very serious question of how everyone sauces their chicken nuggets.See omnystudio.com/listener for privacy information.

On today's MJ Morning Show:MJ is disturbedTwisted Sister's Dee Snyder calls it quitsMorons in the newsMJ is still disturbedOlympicsCreepy MJ taking surreptitious photos The cat left in a couchNew iOs update Comments about Michelle on YouTube LiveCelebs using SEOFester's toenail clippings in the morning show officeMJ & Michelle headed to see Boy GeorgeGuthrie kidnapping updateMcDonald's employee tells customer to leave drive-thruMJ's take on "Landman"MJ went to the bluefin cuttingGrandma showersBailey's class went to a breweryMJ's disturbed feeling (again!)Home Depot sink displayHas fester gotten a new mattress yet? Listener wants to knowRed Lobster newsBest beaches this year from TripAdvisorMJ finally got an electric bill?Guy smashes wrong car in a parking lotSpicy chicken sandwich thrown during argumentBuffalo Wild Wings is allowed use 'boneless chicken wings' on their menuA dad found out his Amazon Echo was recording and storing Hard drive manufacturer says their supply is nearly sold out because of A.I.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode Description: “What's the real story behind that viral crack in Austin's 290 flyover—are we safe, or just trusting the power of a cone?”

This week on Left Standing, I'm joined by Taylor Tieman, founder of Legalmiga — and one of the few internet-savvy attorneys actually translating legalese into language you can understand. (She also loves astrology! Big plus!)If you're a creator, coach, course seller, influencer, or small business owner… this episode is basically your gentle (but firm) legal wake-up call.Taylor breaks down:* Why securing the Instagram handle is not the same thing as protecting your brand* What most entrepreneurs forget to check before naming a podcast, course, or program* How trademark issues usually only come up after someone gets a scary letter* Why legal documents are written to be confusing — and who that benefits* The checklist every online business should have (even though no two businesses are the same)We also get into the reality creators don't talk about publicly:* Speech clauses in brand contracts that can legally restrict what you say online* The financial consequences of breaching a sponsorship agreement* Why some creators stay silent during political moments (and why it's not always cowardice)* The real tension between personal values and contractual obligationsTaylor also shares her perspective as a lawyer navigating a time when the legal system feels slow, reactive, and often outpaced by harm — including her thoughts on corporate PR language (including statements from companies like Home Depot) and the mishandling of sensitive document releases related to the Epstein Files.If you've ever thought:* “I formed an LLC, so I'm good, right?”* “I'll deal with trademarks later.”* “That clause probably won't apply to me.”This episode is your sign to listen first and Google later.Because sometimes the most radical thing you can do as a business owner… is read the fine print. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit carakovacs.substack.com/subscribe

Spencer William Pratt is an American reality television personality and politician. In 2007, he began dating Heidi Montag, a primary cast member of the reality television series The Hills. Subsequently, he came to prominence after being cast in the series. Shop CANTSTOPGOODBOY here: https://shop.cantstopgoodboy.com/ Bobbys World Merchandise from Retrokid: https://retrokid.ca/collections/bobbys-world Howie Mandel Does Stuff available on every Podcast Platform Visit the Official Howie Mandel Website for more: https://www.howiemandel.com/ Howie Mandel Does Stuff Merchandise available on Amazon.com here https://www.amazon.com/shop/howiemandeldoesstuff Join the "Official Howie Mandel Does Stuff" Reddit: https://www.reddit.com/r/HowieMandelPodcast/ Thanks to Our Sponsors: That leaning tower of bins in the garage shouldn't be more stressful than a game show. The HDX Storage System ends the wobbles and guessing games, with totes and shelves that lock together for a perfectly secure, space-saving solution. One System, Endless Possibilities. Get yours now exclusively at The Home Depot! Say Hello to our house band Sunny and the Black Pack! Follow them here! YouTube: https://www.youtube.com/@BlackMediaPresents TikTok: https://www.tiktok.com/@blackmediapresents Spotify: https://open.spotify.com/artist/01uFmntCHwOW438t7enYOO?si=0Oc-_QJdQ0CrMkWii42BWA&nd=1&dlsi=a9792af062844b4f Facebook: https://www.facebook.com/SunnyAndTheBlackPack/ Instagram: https://www.instagram.com/blackmediapresents/ Twitch: https://www.twitch.tv/blackmediapresents Twitter: twitter.com/blackmedia @howiemandel @jackelynshultz @spencerpratt

Re-Release:  On this Live Greatly podcast episode, Kristel Bauer sits down with Joe Kudla, the founder and CEO of Vuori, a performance apparel brand inspired by the active California lifestyle.  Kristel and Joe discuss how and why Vuori got started, the importance of embracing a growth mindset in business and in life, a look into the big lessons Joe has learned from his journey with Vuori and more! Tune in now!  Key Takeaways From This Episode A look into how and why Joe started the performance apparel brand, Vuori How Joe navigates the stress of being a Founder Vuori's Happiness Investment  How Joe uses yoga and breathwork as a stress reliever A big life lesson and a big professional lesson Joe has learned from his time at Vuori Joe's leadership style and how he attracts and keeps top talent at Vuori The importance of embracing a growth minsdet How Joe approaches company culture  The team at Vuori sent Kristel out some complimentary clothing.  About Joe Kudla: Joe Kudla is the founder and CEO of Vuori, a performance apparel brand inspired by the active California lifestyle. A yogi, surfer, outdoorsman and former college athlete, he drew upon his experiences to disrupt the market with A New Perspective on Performance Apparel.  Functional, high‑quality clothing that does not sacrifice style—Built to move in. Styled for life.  Founded in 2015, Vuori received a $400 million investment and $4B valuation from SoftBank Vision Fund 2 in 2021, marking one of the largest investments in a private apparel company. Ernst & Young LLP honored Joe with the Entrepreneur Of The Year® 2022 Pacific Southwest Award. He was also named Glossy's Founder of the Year in 2022.  With a background in accounting, Joe founded the IT consulting firm Vaco SanDiego prior to launching Vuori. Today, he lives in Encinitas, CA with his wife and two children. True to the brand ethos, he still makes time every day to get outside and stay active.  Connect with Vuori Website: https://vuoriclothing.com/  LinkedIn: https://www.linkedin.com/company/vuori-inc-/  Instagram: https://www.instagram.com/vuoriclothing/  Facebook: https://www.facebook.com/vuoriclothing  X: https://twitter.com/vuoriclothing  LinkedIn: https://www.linkedin.com/company/vuori-inc-/  About the Host of the Live Greatly podcast, Kristel Bauer: Book Kristel for Your Event or Team Bring these strategies to your organization:

Wahlburgers cleans up the messy parts of growth so quality stays non-negotiable.  I'm in Las Vegas with Randy Sharpe, CEO, President, and board member of Wahlburgers. He breaks down what he changed, what he cut, and how he plans growth without letting the brand drift.

Support the show: http://www.newcountry963.com/hawkeyeinthemorningSee omnystudio.com/listener for privacy information.

I'm not sure how I feel about it, and honestly it's a little frightening, but somehow John, merritt and Niki spent an entire episode discussing a single topic. I can't remember the last time this happened, and truth be told I'm entirely positive that it's ever happened, but there's a first time for everything I guess. There is one brief but noteworthy diversion about Home Depot, but otherwise I hope you brought your knee pads.Welcome to If You're Driving, Close Your Eyes, a listener-supported comedy podcast where three noble explorers chip away at the crumbling foundations of reality, five or six simultaneous topics at a time. Hosted by Niki Grayson, merritt k and John Warren, and produced by Jordan Mallory, with music by Jordan and art by Max Schwartz.Follow us on Bluesky: https://bsky.app/profile/ifyouredriving.bsky.socialSupport us on Patreon: https://www.patreon.com/ifyouredriving Hosted on Acast. See acast.com/privacy for more information.

SummaryOn this episode of Startup Junkies, hosts Daniel Koonce and Caleb Talley sit down with Phil Pesek, founder of the Law Office of Philip A. Pesek, to unravel the mysteries of business law and compliance for entrepreneurs and startups.With over thirty years of legal experience spanning big-name companies like Dillard's, Walmart, and Home Depot, Phil's journey is packed with stories, insight, and a passion for making the law accessible. After retiring just before the pandemic, Phil discovered his true calling in education—teaching contract law at the University of Arkansas and advising startup founders as a fractional general counsel.Throughout the episode, Phil stresses the importance of compliance, structure, and knowing the “why” behind decisions like forming an LLC or electing S corporation status. He offers a unique, relationship-driven approach by providing a flat fee that includes a fully prepared compliance binder and unlimited access for questions. For new founders, he warns of the traps of DIY legal work from the internet and offers a free initial consultation to make the first steps less daunting.Listeners will find both practical advice and inspiration in Phil's stories—from sobering lessons about the stakes of compliance to encouraging tales of effective contract negotiation. Ultimately, this episode champions seeking out trustworthy legal guidance early and building relationships that will serve your business well as it grows. Tune in today!Show Notes(00:00) Introduction(05:22) S Corps vs LLCs Explained(08:14) Passion for Small Business Ownership(13:02) Demystifying Business Structure Choices(17:22) Separating Personal and Business Assets(22:35) Negotiation Tips for People Pleasers(26:20) Pitfalls of Cutting Legal Corners(31:55) Legal Costs and Quality Concerns(36:54) Closing Thoughts LinksDaniel KoonceCaleb TalleyStartup JunkieStartup Junkie YouTubePhil PesekLaw Office of Phillip A. Pesek

Happy Groundhog Day! Punxsutawney Phil saw his shadow (6 more weeks of winter ☃️), but consumer discretionary stocks are about to heat up!What is Consumer Discretionary?NOT consumer staples (milk, eggs, cereal)The "wants" not "needs" - retailers, restaurants, automakers, home improvementAmazon, Tesla, Home Depot, Lowe's, McDonald's, Chipotle, StarbucksHighly cyclical - outperforms in good times, underperforms in downturnsWhy the Last 5 Years Were Rough:COVID impact on restaurants, brick-and-mortar retail2022: Fed raised rates 7 times (crushed consumer spending)2025: International tariffs pushed up pricesNike, Lululemon: Multiple quarters of negative compsMedian 5-year return: ~9.8% (vs typical 11-12%)Why 2026 Could Be Different:ChatGPT Ads Launch - 1 billion users, new ad format for retailersLower customer acquisition costs - More platforms = cheaper conversionsEasier year-over-year comps - 2025 was terrible, 2026 looks betterInternational brands too cheap - Crocs at 6x free cash flow?!CEO turnarounds - Major brands hiring new leadershipSupply chains stabilizing - Post-tariff efficiency gainsThe ChatGPT Game-Changer:1 billion users (50M paying $200/month for Pro)New ad format: Embedded product suggestions in promptsExample: "Mexican dinner ideas" → Hot sauce ad placementSimilar to Google's playbook: Free product → Monetize with adsRetailers get NEW low-cost acquisition channelStock Opportunities Discussed:- Lovable brands selling cheap: Nike, Lululemon, Crocs- Restaurant plays: Starbucks, Domino's, Chipotle, Cava Group- Software crossover: DraftKings, Duolingo (100M+ users each)- Tesla: Robotaxi progress, new Elon pay package- Adobe: "Dead" due to AI? Still 40% FCF margins, strong retention- The Trade Desk: Collapsed in 2025, cyclical downturn ≠ dead company

In this Live Greatly 2-Minute Motivation podcast episode, Kristel Bauer shares 1 key to being successful and how you can apply it to iachieve you goals. In just two minutes, wou will learn something that can help you create sustainable success in your work and life.

Join Comedians  TDP, Speedy, and Jeff. Lewis is out this week. Jeff talks about his free-basing days. The guys recap their week. Jeff encounters ICE at Home Depot. Enjoy the laughs and remember to donate! Your support is appreciated! Please share, like, subscribe and donate. Thank you! https://patron.podbean.com/inamansworld cash.app/$morrismediastudios Zelle: contact@morrismediastudios.com  #inamansworld  #blackcomedians #funny #morrismediastudios

California Governor Gavin Newsom has emerged with new false claims about the success of his high-speed rail project -- and a creepy legislative proposal to classify as secret any rail-project document that might “harm the interests of the state.” Bonuses! Freshman State Assemblyman David Tangipa tears into the Newsom budget, and Red State editor and investigative reporter Jennifer Van Laar reveals the next chapter in Fresno's secret Chinese bio lab. Music by Metalachi.Email Us:dbahnsen@thebahnsengroup.comwill@calpolicycenter.orgFollow Us:@DavidBahnsen@WillSwaim@TheRadioFreeCAShow NotesCalifornia job market ranks among the weakest of the weak nationwideLabor leaders blast Gavin Newsom over AI, demand more regulationJonathan Turley: Grandstanding Newsom will stop at nothing to ride the rails to glory in 2028State leaders propose to keep some California high-speed rail information secretA top Democrat wants to know if California laws are working. Lawmakers get to pick which onesThrow everything at the wall, see what sticksGun-wielding LA protester aims at feds then vanishes under pepper-ball fireFederal workers face daily harassment by ruthless agitators in DTLA: ‘War zone every day'Coalition rallies to defend Cypress Park day labor center amid disputed Home Depot eviction threatNew twist in mayor's race makes election a referendum on L.A.'s futurePension costs make tax- and fee-hike frenzy at City Hall the new normOvertime costs were skyrocketing. San Diego police say they have reined it in.An ex-Fresno Arts Council employee is under investigation in $1.5 million embezzlement case, city sources sayA Bay Area downtown faces a reckoning as tides riseHow bad was California's ‘Great Flood' of 1862? It was a torrent of horrorsAssemblyman David Tangipa on the state budgetOfficial websiteJen Van Laar on the worst Airbnb in America Illegal Chinese Biolab Used As Airbnb, Made Several Deathly Ill; Defendant Owns Multiple Homes in NV, CAFeds Seize 1000 Samples From Illegal CCP Biolab in Las Vegas Owned by Defendant in Reedley Case Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Take a walk down memory lane with Morgan and Scuba Steve. Morgan decides to orchestra the episode like she's a little kid again, asking any question that comes to mind. They start with their obsession over Barney, which leads them to talk about kids' shows today. Then, they compare the most popular businesses like Walmart vs. Target, Coke vs. Pepsi, & Home Depot vs. Lowes. Plus, they debated water only families and if either of their childhoods experienced the full spread at a restaurant. See omnystudio.com/listener for privacy information.

The episode opens with a sweeping look at the biggest retail stories shaping January. Amazon dominates the headlines again, this time with the closure of all Amazon Fresh grocery and Go stores and a renewed reliance on Whole Foods and online grocery. At the same time, Amazon is laying off tens of thousands of employees, part of a broader wave of cuts across retail and adjacent industries, including UPS, Home Depot, and Nike. The hosts explore whether this is a post-pandemic correction, an AI-driven efficiency shift, or an early signal of bigger structural change.The news turns to Saks Global's bankruptcy, in which most Saks off-price stores will be shut down. This is expected to benefit rivals like Nordstrom Rack and Bloomingdale's Outlet. Earnings signals offer a mixed outlook: LVMH posts weaker results, reinforcing concerns that luxury's recovery will be uneven, while Starbucks shows early signs of traction with traffic growth and the return of tiered loyalty rewards.The second half features an energetic, insight-rich discussion with fellow NRF Top Voices Billy May, Brooklinen's CEO, and David J Katz, EVP and CMO, Randa Apparel, recorded live in the Narvar podcasting studio on the NRF Big Show show floor in New York. Together, they explore how consumer behavior is changing, why value is now deeply contextual, and how trust has become the most fragile currency in retail. They discuss pricing strategy in an era of tariffs, geopolitical risk, and algorithmic pricing, warning that transparency and clarity matter more than ever.The group dives into AI reality—what's working, what's hype, and why AI should be treated as a power tool, not a decision-maker. They examine leadership in the post-COVID era, arguing that execution, speed, and disciplined focus now define winning organizations. Don't miss these rapid-fire takes on rising retailers and the future of the department store—listen now and join the conversation to stay ahead in retail's next chapter.The conversation then shifts to the week's remarkable stories. highlighting the staggering scale of AI investment, including Anthropic's rumored $350 billion valuation and Amazon's possible $50 billion stake in OpenAI. Michael reflects on growing wealth concentration in the U.S. and many developed countries, noting the economic and social implications. Looking around the corner, Steve unpacks TikTok's shifting algorithms, political influence concerns, and TikTok Shop's move to force sellers into its proprietary logistics network—changes that could reshape social commerce. About UsSteve Dennis is a strategic advisor and keynote speaker focused on growth and innovation, who has also been named one of the world's top retail influencers. He is the bestselling author of two books: Leaders Leap: Transforming Your Company at the Speed of Disruption and Remarkable Retail: How To Win & Keep Customers in the Age of Disruption. Steve regularly shares his insights in his role as a Forbes senior retail contributor and on social media.Michael LeBlanc is a senior retail advisor, keynote speaker and media entrepreneur. Michael has delivered keynotes, hosted fire-side discussions hosted senior retail executive on-stage in 1:1 interviews worldwide. Michael produces and hosts a network of leading retail trade podcasts, including The Remarkable Retail Podcast, The Voice of Retail The Food Professor, The FEED powered by Loblaw and the Global eCommerce Leaders podcast. He has been recognized by the NRF as a global Top Retail Voice for 2025 and 2025 and continues to be a ReThink Retail Top Retail Expert for the fifth year in a row.

In this raw, must-watch conversation, former GOP Rep. Joe Walsh joins Matt Lewis to unpack the growing backlash against Trump's second term. They discuss: — The stunning Democratic upset in Texas Senate District 9 (a 31+ point swing from Trump's 2024 margin in a red stronghold) — Why shocking videos of masked ICE agents dragging people from streets/parking lots/Home Depot are turning public opinion (even among non-political Americans) — How tariffs and economic pain are eroding Trump's "secret sauce" Epstein files secrecy fueling distrust, GOP cracks (Massie, Rand Paul pushing back), and why images are more powerful than words in shifting opinion — Walsh's Warning: Trump may try to interfere with 2026 midterms – don't underestimate authoritarian moves — Plus lighter moments on Eagles fandom and calls for prayers over Savannah Guthrie's missing mom in Arizona Walsh (a former Trump voter turned fierce critic) and Lewis (original Never Trumper) argue Democrats could retake the House in a "blue tsunami" driven by Trump's overreach – but must build a real vision for 2028.Subscribe to Matt Lewis on Substack: https://mattklewis.substack.com/Support Matt Lewis at Patreon: https://www.patreon.com/mattlewisFacebook: https://www.facebook.com/MattLewisDCTwitter: https://twitter.com/mattklewisInstagram: https://www.instagram.com/mattlewisreels/YouTube: https://www.youtube.com/channel/UCVhSMpjOzydlnxm5TDcYn0A– Who is Matt Lewis? –Matt K. Lewis is a political commentator and the author of Filthy Rich Politicians.Buy Matt's books: FILTHY RICH POLITICIANS: https://www.amazon.com/Filthy-Rich-Politicians-Creatures-Ruling-Class/dp/1546004416TOO DUMB TO FAIL: https://www.amazon.com/Too-Dumb-Fail-Revolution-Conservative/dp/0316383937Copyright © 2026, BBL & BWL, LLC

At 17 years old, Aaron Steed started a business with no trucks, no money, and no safety net. Today, Meathead Movers generates $20 million annually, employs 350 people, and has landed on the Inc. 5000 list for eight straight years.In this episode of UpFlip, Aaron reveals how he disrupted a "boring" industry by turning hustle into a visible competitive advantage. He explains why his movers jog whenever they aren't carrying boxes, how he used a "Pay What You Want" model to build early trust, and why he actively helps his employees leave the company to pursue their dream careers.In this episode, you'll learn:The "Jogging" MO: How Meathead Movers disrupted the industry by requiring employees to jog when not carrying items—creating visible value for the customer.The "Pay What You Want" Strategy: The risky pricing model Aaron used for the first three years to build an undeniable reputation (and when he finally stopped using it).Guerrilla Marketing 101: The exact script Aaron used in Home Depot and Costco parking lots to land jobs with zero ad spend.The "Stepping Stone" Culture: Why Aaron calls his employees' future employers to recommend them, and how this reduces turnover and attracts top talent.The Money-Back Guarantee: How to structure a refund policy based on the customer's perceived value of each individual employee.From Friend to Boss: The leadership transition required when scaling from a high school side hustle to a corporate organization.The "Engine vs. Mechanic" Mindset: Why you must stop being a piece of the engine (working in the business) and start being the mechanic (working on the business) to scale.Hiring for Grit: How to identify candidates who have the physical and mental endurance for hard labor while maintaining a smile.Surviving Near-Death: Aaron shares how the company survived four separate events that almost wiped them out completely.The $200 Marketing Plan: Why business cards and eye contact still beat digital ads for local service businesses starting out.Tags: Trucking, Service & Consulting, Business leadership, Side hustle, Meathead Movers, Delivery business, Boring BusinessResources:Grow your transportation business today: https://www.upflip.com/course/moving-and-junk-removal-blueprintConnect with Aaron: https://www.instagram.com/meatheadmovers/?hl=en

Sal Licata joins the crew today, and you'll never guess how Christopher "Mad Dog" Russo tried to pronounce Jarrett Stidham. We discovered that Sal was a ladies' man when he worked at Home Depot in the past. Then, the Mets made moves adding pitcher Freddy Peralta and outfielder Luis Robert Jr., and we get Sal's take on it. Stugotz thinks the Bills should hire Bill Belichick. And finally, we discuss the etiquette of buying Girl Scout cookies. See omnystudio.com/listener for privacy information.

Rachel Maddow shares recent examples of prominent members of the clergy speaking out against Donald Trump's abuse anti-immigrant tactics and his belligerent foreign policy, and talks with Cardinal Blase Cupich, archbishop of Chicago, about defending immigrant members of his community and Donald Trump's dismantling of the moral role the U.S. plays in the world.Rachel Maddow reports on a growing number of towns and communities that are speaking out and standing up to Department of Homeland Security plans to open ICE detention and processing facilities to take in immigrants being arrested in federal raids. The rejection of ICE facilities fits into a bigger picture of pressure being put on companies and organizations that have become tacit ICE resources, from Avelo Airlines conducting deportation flights, to Home Depot allowing arrests of day laborers in their parking lots.Rachel Maddow shares photos of a giant replica of the naked woman birthday doodle that appears to have been from Donald Trump to Jeffrey Epstein on his 50th birthday. The replica is meant to commemorate Trump's relationship with Epstein as Epstein's birthday approaches. Want more of Rachel? Check out the "Rachel Maddow Presents" feed to listen to all of her chart-topping original podcasts.To listen to all of your favorite MS podcasts without ads, sign up for MS NOW Premium on Apple Podcasts. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.